Service Communautaire d'Information sur la Recherche et le Développement - CORDIS

  • Commission européenne
  • CORDIS
  • Projets et résultats
  • Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

Feasibility study for the validation and industrialization of two diagnostic kits in both ELISA and CLIA formats for the early detection of pancreatic cancer based on the novel biomarkers EZR and ENOA

De 2015-05-01 à 2015-10-31, projet clôturé

Détails concernant le projet

Coût total:

EUR 71 429

Contribution de l'UE:

EUR 50 000

Coordonné à/au(x)/en:

Italy

Appel à propositions:

H2020-SMEINST-1-2014See other projects for this call

Régime de financement:

SME-1 - SME instrument phase 1

Objectif

Coordinateur

NATIMAB THERAPEUTICS SRL
Italy

Contribution de l'UE: EUR 50 000


VIA RIBES 5
10010 COLLERETTO GIACOSA TORINO
Italy
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)